| P50 | author | Martin Bornhäuser | Q61053345 |
| P2093 | author name string | Lothar Kanz | |
| | Dietrich W Beelen | |
| | Gerhard Behre | |
| | Matthias Stelljes | |
| | Maximilian Christopeit | |
| | Rupert Handgretinger | |
| | Christoph Meisner | |
| | Rainer Schwerdtfeger | |
| | Wolfgang A Bethge | |
| | Christoph Faul | |
| | Michael Schumm | |
| | Wichard Vogel | |
| | Gernot Stuhler | |
| | Birgit Federmann | |
| | Lambros Kordelas | |
| P2860 | cites work | Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation | Q66829606 |
| | Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow ino | Q71654487 |
| | Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT | Q74422560 |
| | A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors | Q74445815 |
| | Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype | Q77437408 |
| | Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: comparison of a volumetric assay and the ISHAGE gating strategy | Q77567786 |
| | Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device | Q77816241 |
| | Stable engraftment after megadose blood stem cell transplantation across the HLA barrier: the case for natural killer cells as graft-facilitating cells | Q78067611 |
| | Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity | Q79420957 |
| | Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation | Q80168024 |
| | Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation | Q81380531 |
| | Long-term follow-up of a pilot study using a chemotherapy-alone protocol for killer Ig-like receptor-ligand-mismatched haploidentical haematopoietic SCT | Q82852534 |
| | Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts | Q85190974 |
| | Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 |
| | Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors | Q33358178 |
| | The role of accessory cells in allogeneic peripheral blood stem cell transplantation. | Q33539921 |
| | Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. | Q33841389 |
| | NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect | Q33984778 |
| | Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation | Q34162461 |
| | Facilitating cells as a venue to establish mixed chimerism and tolerance | Q35635744 |
| | KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation | Q35848151 |
| | Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. | Q35850712 |
| | Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment | Q36403190 |
| | Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors | Q36976857 |
| | HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide | Q37078261 |
| | Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity | Q37209082 |
| | The EBMT risk score | Q37885167 |
| | Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis | Q40348802 |
| | Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis | Q40566531 |
| | Prediction of cumulative incidence function under the proportional hazards model | Q40863181 |
| | Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine | Q42028666 |
| | Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. | Q44743006 |
| | Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma | Q44905104 |
| | Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. | Q45309204 |
| | A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation | Q46965159 |
| | Revised response criteria for malignant lymphoma | Q47582438 |
| | Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis | Q47589093 |
| | A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation | Q48034933 |
| | Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. | Q50872473 |
| | Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. | Q50911359 |
| | A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. | Q51315475 |
| | Analysis of survival by tumor response. | Q52874285 |
| | Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. | Q55033128 |
| | Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma | Q57209660 |
| | Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes | Q57589057 |
| | A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation | Q66829333 |
| P433 | issue | 10 | |
| P304 | page(s) | 1523-1531 | |
| P577 | publication date | 2012-04-04 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study | |
| P478 | volume | 97 | |